Market Overview

Not Too Late to Buy Baxter, Jim Cramer Says

Related BAX
Earnings Scheduled For April 26, 2016
Baxter One Of Several Firms Said To Be Exploring An Acquisition Of India-Based Gland Pharma
Baxter Raises Guidance As Hospital Market Rebounds; Stock Hits High (Investor's Business Daily)

Coming out of the Twittersphere late Thursday night: Jim Cramer offers advice to an investor who missed out on scooping up shares of Baxter International (NYSE: BAX) before the company announced a breakup into two separate, independent global healthcare companies.

Cramer, who correctly predicted Baxter's breakup, believes the stock can still be bought.

Shares of Baxter opened at $75.68, but closed at $72.80, finishing up 3.8 percent on Thursday.

Posted-In: Jim CramerAnalyst Color Jim Cramer Media Trading Ideas


Related Articles (BAX)

View Comments and Join the Discussion!